sur Theranexus (EPA:ALTHX)
Theranexus Unveils 2025 Financial Calendar
Theranexus, a biopharmaceutical firm specializing in rare neurological diseases, has disclosed its financial communication schedule for 2025. Each announcement is slated for release post-Euronext market closing. The timeline is tentative and subject to adjustments.
The key dates in the calendar include the cash position announcement as of December 31, 2024, on February 13, 2025. The 2024 annual results and cash position for March 31, 2025, will be shared on April 29, 2025. The Shareholders' General Meeting is set for June 26, 2025. Reports on cash position as of June 30 and September 30 will be presented on July 10 and October 23, respectively, along with the half-year results on September 25, 2025.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Theranexus